Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer

Pancreatic cancer is among the most lethal malignant neoplasms, and few patients with pancreatic cancer benefit from immunotherapy. We retrospectively analyzed advanced pancreatic cancer patients who received PD-1 inhibitor-based combination therapies during 2019–2021 in our institution. The clinica...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xin Qiu, Zhan Shi, Fan Tong, Changchang Lu, Yahui Zhu, Qiaoli Wang, Qing Gu, Xiaoping Qian, Fanyan Meng, Baorui Liu, Juan Du
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2023-01-01
Edice:	Human Vaccines & Immunotherapeutics
Témata:	pancreatic cancer pd-1 inhibitors inflammatory markers liver metastasis biomarkers
On-line přístup:	http://dx.doi.org/10.1080/21645515.2023.2178791
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!